Commission Implementing Decision (EU) 2017/1445 of 8 August 2017 on the group of products whose principal intended action, depending on proanthocyanidins (PAC) present in cranberry (Vaccinium macrocarpon), is to prevent or treat cystitis (notified under document C(2017) 5341)

CELEX: 32017D1445
Document type: DEC_IMPL
Sector: Legislation
Date of document: 2017-08-08
In force since: 2017-08-10
Status: In force
ELI: http://data.europa.eu/eli/dec_impl/2017/1445/oj

Text

Article-level text, parsed from the formex manifestation.

Article 1

The group of products whose principal intended action, depending on proanthocyanidins present in cranberry (Vaccinium macrocarpon) extract, is to prevent or treat cystitis, does not fall within the definition of medical devices set out in point (a) of Article 1(2) of Directive 93/42/EEC.

Article 2

This Decision is addressed to the Member States.

Relations

What this act cites, and what cites it.

Show relations

Versions

Point-in-time consolidated versions of this act.

Show versions